Articles

Home /Articles / FDA Federal Register Notices

No article fund in this category

Top News

LyfeUnit Selling Unapproved Ketamine Products: FDA
FDA Moves to Cement Complete Response Letter Transparency Policy
Companies Can Use AI to Prepare for Inspections
QuVa Pharma Inspection Observations
Vera Therapeutics' Trutakna Approved for IgA Nephropathy
FDA Cites Lundbeck Over Vyepti Promotional Claims
Saol Therapeutics Resubmits Rare Disease Therapy SL1009
FDA Plans Rule to Require Full Risk Info in Drug Ads

Prev

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Dickinson's FDA Webview is the interactive Web site that watches the U.S. Food and Drug Administration all day long. From the leading publisher of FDA-content business newsletters since 1984, you can monitor regulatory, legal, policy and scientific news affecting all FDA-regulated healthcare products and their marketing activities.